VIDEO: Drug-Eluting Stents Lower Revascularization Rates, Hormone Therapy for Prostate Cancer May Increase Death Risk, Testosterone Therapy May Benefit Heart Failure Patients

27.08.2009 | 1:28 min

(August 27, 2009 - Insidermedicine) From New York - According to research in the Journal of the American College of Cardiology, drug-eluting stents can reduce revascularization rates. In a study of over 1,700 patients, researchers found that the sirolimus-eluting coronary stent reduced the need for revascularization by 50%, compared to a bare metal stent. Both groups had similar rates of death and heart attack. From Boston - According to research in the Journal of the American Medical Association, hormone therapy for prostate cancer may increase the risk of death in some men. In a study of over 5,000 men, researchers found that hormonal therapy for prostate cancer doubled the risk of death among those with congestive heart failure or heart attack, secondary to coronary artery disease. And finally, from Rome - According to research in the Journal of the American College of Cardiology, testosterone therapy may benefit elderly men with heart failure. In a study of 70 older men, researchers found that testosterone injections improved strength, endurance and physical function, as well as peak oxygen consumption. The long-term safety of this treatment is not yet known. For Insidermedicine in 60, I'm Dr. Kelly Schweitzer.
© ℗ & © 2007 CEH Inc.